Overview
March 2, 2016 - Tutorial (PM)*
March 3-4, 2016 - Conference
*Tutorials require registration and are an additional fee
Now in its 27th year, the DIA Marketing Pharmaceuticals 2016 Planning Team created a program that celebrates the conference components you look forward to each year while INCREASING the number of varied content offerings, INTRODUCING new interactive session formats, and providing MORE structured networking opportunities.
This conference is designed for professionals working through regulatory and compliance challenges in the marketing, advertising, and promotion of pharmaceuticals, veterinary products, biologics, and medical devices.
NEW Conference Features:
- Attend a DIA Advertising and Promotion Working Group (APWG) Meeting – meet members from DIA’s Regulatory Affairs Ad Promo community and learn how to get involved on March 2, 5:15-6:30PM.
- DIA Mobile App – keep connected throughout the conference and engage in session polls
- Round Table Discussion Luncheon – conversations inspired by sessions and led by community leaders on March 4, 11:30AM-1:00PM.
- Poster Presentations – view poster presentations throughout the conference
- More Interactive Sessions – learn from industry experts and from each other through panel and audience discussion
“Why Do I Attend DIA’s Marketing Pharmaceuticals Conference?” Top 5 Responses from Attendee Survey. TO:
- interact with OPDP leadership and personnel
- network with my industry colleagues and meet current and future clients
- participate in a Live information exchange between industry and government on best practice trends and issues
- learn the latest industry best practices and guidelines
- earn ACPE and IACET credits
Program Committee
-
Thomas W. Abrams, MBA, RPh Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Former FDA, United States -
Glenn N. Byrd, MBA President
GByrd Ad-Promo Solutions, LLC, United States -
Dale Cooke, JD, MA President
Phillycooke Consulting, United States -
Mark Gaydos Former Global Head, Advertising & Promotion, Global Regulatory Affairs
Sanofi, United States -
Lynette Hopkinson Vice President, Commercial Regulatory Affairs, Global Regulatory Affairs
Vertex Pharmaceuticals Incorporated, United States -
John T. Murray President
Grayscale Compliance LLC, United States -
Wayne Pines President, Health Care
United States -
Lucy Rose, MBA President
Lucy Rose and Associates, United States -
Kristina Vlaovic, MPH Vice President, Regulatory, Safety and Pharmacovigilance
HALOZYME Inc., United States
Have an account?